Literature DB >> 27490081

Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.

Andrew Etsano, Eunice Damisa, Faisal Shuaib, Gatei Wa Nganda, Ogu Enemaku, Samuel Usman, Adekunle Adeniji, Jaume Jorba, Jane Iber, Chima Ohuabunwo, Chimeremma Nnadi, Eric Wiesen.   

Abstract

In September 2015, more than 1 year after reporting its last wild poliovirus (WPV) case in July 2014 (1), Nigeria was removed from the list of countries with endemic poliovirus transmission,* leaving Afghanistan and Pakistan as the only remaining countries with endemic WPV. However, on April 29, 2016, a laboratory-confirmed, circulating vaccine-derived poliovirus type 2 (cVDPV2) isolate was reported from an environmental sample collected in March from a sewage effluent site in Maiduguri Municipal Council, Borno State, a security-compromised area in northeastern Nigeria. VDPVs are genetic variants of the vaccine viruses with the potential to cause paralysis and can circulate in areas with low population immunity. The Nigeria National Polio Emergency Operations Center initiated emergency response activities, including administration of at least 2 doses of oral poliovirus vaccine (OPV) to all children aged <5 years through mass campaigns; retroactive searches for missed cases of acute flaccid paralysis (AFP), and enhanced environmental surveillance. Approximately 1 million children were vaccinated in the first OPV round. Thirteen previously unreported AFP cases were identified. Enhanced environmental surveillance has not resulted in detection of additional VDPV isolates. The detection of persistent circulation of VDPV2 in Borno State highlights the low population immunity, surveillance limitations, and risk for international spread of cVDPVs associated with insurgency-related insecurity. Increasing vaccination coverage with additional targeted supplemental immunization activities and reestablishment of effective routine immunization activities in newly secured and difficult-to-reach areas in Borno is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27490081     DOI: 10.15585/mmwr.mm6530a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  24 in total

1.  Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.

Authors:  Guihua Tang; Wen Yin; Youde Cao; Liming Tan; Shuyu Wu; Yudong Cao; Xianyong Fu; Jing Yan; Xingjun Jiang
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

Review 2.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

3.  Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan.

Authors:  Dominika A Kalkowska; Radboud J Duintjer Tebbens; Mark A Pallansch; Kimberly M Thompson
Journal:  Risk Anal       Date:  2018-10-08       Impact factor: 4.000

4.  Poliovirus immunity among children under five years-old in accessible areas of Afghanistan, 2013.

Authors:  Christopher H Hsu; Kathleen A Wannemuehler; Sajid Soofi; Mohd Mashal; Imtiaz Hussain; Zulfiqar A Bhutta; Larin McDuffie; William Weldon; Noha H Farag
Journal:  Vaccine       Date:  2019-02-16       Impact factor: 3.641

5.  Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.

Authors:  Dominika A Kalkowska; Richard Franka; Jeff Higgins; Stephanie D Kovacs; Joseph C Forbi; Steven G F Wassilak; Mark A Pallansch; Kimberly M Thompson
Journal:  Risk Anal       Date:  2020-04-29       Impact factor: 4.000

6.  Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria.

Authors:  Dominika A Kalkowska; Kimberly M Thompson
Journal:  Risk Anal       Date:  2020-04-29       Impact factor: 4.000

7.  Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

Authors:  Kun Zhao; Jaume Jorba; Jing Shaw; Jane Iber; Qi Chen; Kelley Bullard; Olen M Kew; Cara C Burns
Journal:  Comput Struct Biotechnol J       Date:  2017-10-12       Impact factor: 7.271

8.  Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.

Authors:  Mona Marin; Manisha Patel; Steve Oberste; Mark A Pallansch
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-13       Impact factor: 17.586

9.  Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.

Authors:  Elizabeth B Brickley; Carolyn B Strauch; Wendy F Wieland-Alter; Ruth I Connor; Shu Lin; Joshua A Weiner; Margaret E Ackerman; Minetaro Arita; M Steven Oberste; William C Weldon; Xavier Sáez-Llorens; Ananda S Bandyopadhyay; Peter F Wright
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

10.  Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.